TIER

TIER: A Phase I/II Study of Thiotepa, Ifosphamide, Etoposide and Rituximab for the treatment of relapsed or refractory primary central nervous system lymphoma

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. 

Trial Documents

Links to the current protocol, Patient Information Sheet, Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the TIER Trial Office.

Current Essential Documents

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. Links to the Version Control Lists used in this trial are below in reverse date order.

Current

Previous

Amendments

Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

Guidelines

Pharmacy

Pharmacy Documents

Pharmacy File Version Control Checklists

Publications

To date there are no publications for this trial.

News and Events

No current news or upcoming events

Tier Newsletters

Tier Flyers

 

Contact Details

Chief Investigator:
Dr Christopher Fox
Centre for Clinical Haematology
Nottingham University Hospitals (City Campus)
Hucknall Road
Nottingham
NG5 1PB

 Email: Tier@trials.bham.ac.uk

Tel: +44 (0)115 969 1169
Fax:+44 (0)115 993 6635

TIER Trial Office     

Trial Coordinator:  Louise Hopkins
Trial Monitor:  Poonam Patel / Semsem Abdulle
Trial Management Team Leader:  Sonia Fox
Trial Statistician:  Anesh Panchal

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Enquiries
Telephone: +44 (0)121 414 7673
Fax:             +44 (0)121 414 6061
Email:         Tier@trials.bham.ac.uk

Trial Entry
Telephone: +44 (0)121 414 7673

Serious Adverse Event Reporting
Fax:  +44 (0)121 414 6061

Trial Sponsor
Unversity of Birmingham